0000899243-19-010033.txt : 20190404
0000899243-19-010033.hdr.sgml : 20190404
20190404183707
ACCESSION NUMBER: 0000899243-19-010033
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190402
FILED AS OF DATE: 20190404
DATE AS OF CHANGE: 20190404
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Singhal Priya
CENTRAL INDEX KEY: 0001769608
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36510
FILM NUMBER: 19733183
MAIL ADDRESS:
STREET 1: C/O ZAFGEN, INC.
STREET 2: 175 PORTLAND STREET 4TH FL
CITY: BOSTON
STATE: MA
ZIP: 02114
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ZAFGEN, INC.
CENTRAL INDEX KEY: 0001374690
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 203857670
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 175 PORTLAND STREET
STREET 2: 4TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02114
BUSINESS PHONE: 617-622-4003
MAIL ADDRESS:
STREET 1: 175 PORTLAND STREET
STREET 2: 4TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02114
FORMER COMPANY:
FORMER CONFORMED NAME: ZAFGEN INC
DATE OF NAME CHANGE: 20060906
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-04-02
0
0001374690
ZAFGEN, INC.
ZFGN
0001769608
Singhal Priya
C/O ZAFGEN, INC., 4TH FLOOR
175 PORTLAND STREET
BOSTON
MA
02114
0
1
0
0
Head of Research & Development
Stock Option (Right to Buy)
2.89
2019-04-02
4
A
0
375000
0.00
A
2029-03-03
Common Stock
375000
375000
D
25% of this option vests on March 4, 2020, and the remainder vests in equal monthly installments thereafter over 36 months. The option has been granted pursuant to an inducement award agreement outside of the company's 2014 Stock Option and Incentive Plan as a material inducement to the reporting person's acceptance of employment with the company in accordance with NASDAQ Listing Rule 5635(c)(4). The option is subject to acceleration upon a change in control.
/s/ Shoaib Ghias, Attorney-In-Fact
2019-04-04